Skip to main content
Caplight Logo









EktaH

EktaH

Private
DijonHealthcare & Life Scienceshttps://ektah.com

Last Round

Crowdfunding

Dec 31, 2024

Est. Valuation

$5.24M

Total Funding Raised

$1.24M

Company Overview

EktaH operates in Healthcare & Life Sciences and is based in Dijon. Its latest recorded funding round was a Crowdfunding round in December 2024.

EktaH is a biotechnology company that develops oral therapies for obesity and metabolic diseases by targeting fat taste receptors to regulate satiety.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EktaH Comparables

Compare EktaH with similar companies based on industry and business-model similarity.

EktaH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Palate Therapeutics
77%
Kailera Therapeutics
71%
Structure Therapeutics
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EktaH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingDec 31, 2024
SeedFeb 7, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EktaH Investors

Notable investors and investment history

EktaH investors
InvestorRounds
SAYENSSeed
UI InvestissementVC Round
BpifranceSeed
Capital CellCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2026

    Monthly visitors increased 172% MoM.

  • Apr 16, 2026

    Monthly visitors grew 262% MoM, from 347 to 1.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

EktaH Filings

Explore SEC and related filing metadata, where available.

EktaH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EktaH's valuation, stock price, and market status.

Is EktaH a public or private company?

EktaH is a private company.

What is the current stock price of EktaH?

EktaH is a private company, so its shares have no public market price. Caplight tracks EktaH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EktaH worth (valuation)?

EktaH's valuation is estimated at $5.2M based on funding round data.

Can I buy EktaH stock?

EktaH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EktaH's last funding round?

EktaH's most recent funding round was Crowdfunding on December 31, 2024.

Who are the main investors in EktaH?

Key investors in EktaH include SAYENS, UI Investissement.

Will EktaH IPO soon?

No public IPO plans have been announced for EktaH.

How can I track EktaH secondary market activity?

Caplight tracks bids, offers, and trades in EktaH's shares on secondary markets.

Firmographic Details

HeadquartersDijon
Employee Range2
Year Founded2021
Last FundingDec 31, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?